Quetiapine: Clinical Trials

180 trials of Quetiapine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

116 completed, 25 terminated, 24 unknown, 6 recruiting. 73 Phase 4, 47 Phase 3, 25 Phase 2, 19 Not applicable, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 473Completed 53, Unknown 8, Terminated 5, Withdrawn 4, Recruiting 2, Active not recruiting 1
Phase 347Completed 28, Terminated 11, Recruiting 3, Unknown 3, Not yet recruiting 1, Withdrawn 1
Phase 225Completed 15, Terminated 7, Recruiting 1, Unknown 1, Withdrawn 1
Not applicable19Completed 12, Unknown 6, Not yet recruiting 1
Phase 111Completed 5, Unknown 4, Active not recruiting 1, Terminated 1
Early Phase 12Terminated 1, Unknown 1

Follow Quetiapine: new trials by email Literature Review of Quetiapine trials Research Report on Quetiapine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Trazodone, Quetiapine, Placebo - Delirium, Morality
Phase 4WithdrawnUniversity of Southern California2028-03-012026-05-04
Study of rTMS in Maintenance in Treatment Resistant Depression
Transcranial Magnetic Stimulation, quetiapine - Treatment Resistant Depression (TRD)
Phase 3Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar682026-08-302026-08-12
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder
Phase 3RecruitingDr. Inge Winter12542025-04-272026-01-22
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Escitalopram, Sertraline, Venlafaxine - Bipolar Depression
Phase 3RecruitingDr. Inge Winter4182025-02-112025-09-26
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
Cariprazine, Aripiprazole/Escitalopram combination, Quetiapine - Bipolar I Disorder, Depression
Phase 4Active not recruitingMassachusetts General Hospital27262024-10-012025-12-16
Quetiapine Versus Trazadone in Women With Postpartum Depression
Trazodone, Quetiapine - Postpartum Depression
Early Phase 1UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's502024-09-012024-08-09
Trazodone vs. Quetiapine for the Treatment of ICU Delirium
Trazodone, Quetiapine - Delirium, Delirium of Mixed Origin
TerminatedUniversity of Southern California102024-06-012026-05-04
Improving Sleep After TKA Using Mirtazapine and Quetiapine
Mirtazapine, Quetiapine, Placebo - Osteo Arthritis Knee, Insomnia
Not applicableNot yet recruitingSt. Anna Ziekenhuis, Geldrop, Netherlands1652024-01-012023-06-02
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
Melatonin, Quetiapine, Placebo - Psychiatric Disorders, Insomnia
Phase 2 / Phase 3RecruitingLone Baandrup2552023-09-182025-04-24
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
Valproate, Quetiapine, Standard of Care - Covid19, Hyperactive Delirium
Phase 4WithdrawnUniversity of Miami2023-03-282023-03-31
Quetiapine in Prevention of Delirium
Quetiapine - Delirium
Phase 2CompletedAin Shams University902023-03-012023-07-10
Quetiapine as Prophylaxis for Delirium in CABG
Quetiapine - Delirium
Not applicableUnknownAin Shams University602022-12-042023-04-06
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Pimavanserin, Quetiapine - Parkinson's Disease Psychosis
Phase 4RecruitingVA Office of Research and Development3582022-10-242026-08-19
Sleep Disorders in Chronic Kidney Disease Patients
Quetiapine - Chronic Kidney Diseases
Phase 1UnknownAssiut University602022-05-012022-02-15
Comparing Antipsychotic Medications in LBD Over Time
Pimavanserin, Quetiapine - Parkinson's Disease Psychosis, Dementia With Lewy Bodies
Phase 4RecruitingThe University of Texas Health Science Center at San Antonio942022-04-222025-09-09
The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
Quetiapine - Postpartum Depression
Phase 1Active not recruitingVerinder Sharma222022-03-182025-03-05
Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression
Quetiapine, Amantadine, Pramipexole - Treatment Resistant Depression
Phase 4UnknownAll India Institute of Medical Sciences, Bhubaneswar1502021-08-072023-08-22
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
Risperidone, Aripiprazole, Ziprasidone - Schizophrenia
Phase 4UnknownShanghai Mental Health Center3502021-05-012020-08-26
Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control
Quetiapine - Bipolar Affective Disorder
Not applicableUnknownFederal Stare Budgetary Scientific Institution, Mental Health Research Center302021-04-102021-10-28
Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics
Risperidone, Olanzapine, Quetiapine - Antipsychotics and Neuroleptics Toxicity
Not applicableCompletedDr Rabia Arshad1402021-01-012024-01-11

Showing 20 of 180. Sign in to see all of them.

Conditions studied

Schizophrenia (54)  ·  Bipolar Disorder (41)  ·  Psychotic Disorders (32)  ·  Depression (12)  ·  Depressive Disorder, Major (11)  ·  Delirium (10)  ·  Dementia (9)  ·  Alcoholism (6)  ·  Phobia, Social (6)  ·  Psychomotor Agitation (6)  ·  Sleep Initiation and Maintenance Disorders (6)  ·  Mania (5)  ·  Substance-Related Disorders (5)  ·  Alzheimer Disease (4)  ·  Anxiety Disorders (4)

Sponsors

AstraZeneca (9)  ·  University of Cincinnati (7)  ·  Massachusetts General Hospital (6)  ·  Astellas Pharma Inc (4)  ·  H. Lundbeck A/S (4)  ·  New York State Psychiatric Institute (4)  ·  Fundación Marques de Valdecilla (3)  ·  Janssen Scientific Affairs, LLC (3)  ·  National Institute of Mental Health (NIMH) (3)  ·  Shanghai Mental Health Center (3)  ·  University of California, San Diego (3)  ·  University of Southern California (3)  ·  University of Texas Southwestern Medical Center (3)  ·  Ain Shams University (2)  ·  All India Institute of Medical Sciences, Bhubaneswar (2)

Countries

United States (90)  ·  Germany (18)  ·  Canada (17)  ·  China (9)  ·  Spain (9)  ·  Japan (6)  ·  Russia (6)  ·  South Korea (6)  ·  Argentina (5)  ·  Czechia (5)  ·  Taiwan (5)  ·  Ukraine (5)  ·  Brazil (4)  ·  Denmark (4)  ·  Estonia (4)

Top investigators

Benedicto Crespo-Facorro, Professor (3)  ·  Melissa P DelBello, MD (3)  ·  John J Mariani, MD (2)  ·  Alan I Green, MD (1)  ·  Albert J Arias, MD, MS (1)  ·  Amy Yule, M.D. (1)  ·  Ana Gonzalez Pinto (1)  ·  Anders Fink-Jensen, MD, professor, DMSci. (1)  ·  Andre Tapp, M.D. (1)

Results publications

PMID 32792252, PMID 22035648, PMID 24816198, PMID 29856773, PMID 30097769, PMID 32840872, PMID 37756123, PMID 38958149, PMID 41401709, PMID 10082232, PMID 12075033, PMID 15082703, PMID 15817019, PMID 1593914, PMID 16172203, PMID 16585434, PMID 16585435, PMID 16831113, PMID 17035647, PMID 17151158, PMID 17151159, PMID 17984395, PMID 18041437, PMID 18058285, PMID 18312058, PMID 18519523, PMID 19157776, PMID 19347026, PMID 19358791, PMID 19369318, PMID 19640511, PMID 19687169, PMID 19752841, PMID 19865006, PMID 19963274, PMID 20048218, PMID 20184807, PMID 20214847, PMID 20334680, PMID 20565430, PMID 20572379, PMID 20701823, PMID 20724402, PMID 20816031, PMID 20868641, PMID 20879830, PMID 21346616, PMID 21536693, PMID 21733490, PMID 21884578

NIH funding

2005 (2), 2009 (2), 2023 (2), N01MH090001 (2), N01MH90001 (2), 2008 (1), 2019 (1), K12DA000357 (1), K23DA021209 (1), P30MH086045 (1), P50DA009236 (1), R01DA022221 (1), R01DA031826 (1), R01MH057292 (1), R01MH059101 (1)